At COO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Australia based COO’ operating in the Biotechnology space. If you think a COO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Stewart Bartlett
Co-Founder & COO of Signostics
Mr. Bartlett is a co-founder of Signostics. He managed all product development and research at Signostics from inception, as well as making important contributions to strategy and business development. He has 20 years experience in product development and management. His experience includes manufacturing management, product commercialization, intellectual property, as well as sales and marketing. He held several management positions at Lake Technology Ltd, including Managing Director of a subsidiary responsible for licensing Lake’s technology to consumer electronics and personal computer manufacturers. He received a Bachelor of Electrical Engineering with Honors from Curtin University and a Master of Business Administration from the Australian Graduate School of Management.
Follow Stewart Bartlett:
About Signostics: Signostics, a medical device company, provides clinicians with handheld tools for use at the point-of-care.
David Seaton
COO of EnGeneIC
Follow David Seaton:
About EnGeneIC: EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.
Gary Dunne
COO of Sigma Healthcare
COO at Sigma Pharmaceuticals
Follow Gary Dunne:
About Sigma Healthcare: Sigma Healthcare engages in the wholesale distribution of pharmaceutical products and the provision of services to retail
Frank Oly
Co-Founder and COO of Loam Bio
Frank Oly is the Co-Founder and COO at Loam.
Follow Frank Oly:
About Loam Bio: Loam Bio is developing tech that allows for crops to be inoculated with symbiotic micro-organisms.
Sara Prickett
Chief Operating Officer and Co-Founder of Aravax
Sara Prickett is the COO and co- founder of Arvax. She has over 15 years’ research experience in cellular immunology and was responsible for the preclinical development of Aravax’s peanut allergy therapy. Prior to Aravax, Dr Prickett held senior research posts within Alfred Health and Monash University. Dr Prickett received her Bachelor of Science from Sheffield University and PhD from Imperial College, London.
Follow Sara Prickett:
About Aravax: Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.
James Shaw
COO of Neuren Pharmaceuticals
James joined Neuren in August 2013 and brings twenty years of development and commercialisation experience in the Pharmaceutical Industry, having worked for both large Pharma and Clinical Research Organisations (CROs). Before joining Neuren, he was CEO of a Clinical Research and Site Management Organisation providing full service clinical trial support in ANZ. Prior to that he spent 7 years with Quintiles in Sydney and Singapore working across Business Development and Operational leadership roles. James brings a global focus to drug development, having led product teams from Phase II through to FDA submission and commercialisation during six years with AstraZeneca at their Global HQ in the UK.
Follow James Shaw:
About Neuren Pharmaceuticals: Neuren Pharmaceuticals is a biopharmaceutical company developing drugs for the treatment of brain injuries and neurodegeneration.
Joanne Alcindor
Founder, Director and COO of MecRx
Joanne Alcindor is the Founder, Chief Operating Officer and Director at MecRx. Jo is responsible for the management of MecRx’s research programs and company operations.
Follow Joanne Alcindor:
About MecRx: MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics.
Kilian Kelly
Chief Operating Officer of Cynata
Follow Kilian Kelly:
About Cynata: Cynata is a life sciences technology business.
Riccardo Massaro
COO – Co-Founder of Uira BioenergEthic
Follow Riccardo Massaro:
About Uira BioenergEthic: Get your limited edition apparels now and support us to kickstart their venture.
David Rhodes
Chief Operating Officer of AdAlta
Follow David Rhodes:
About AdAlta: AdAlta is a biotech company that develops and commercializes protein-based therapeutics.
David Rhodes
Chief Operating Officer of AdAlta
Follow David Rhodes:
About AdAlta: AdAlta is a biotech company that develops and commercializes protein-based therapeutics.